Tactile Systems Technology, Inc. reported a 12% increase in first-quarter revenue, driven by sales of airway clearance products, specifically the AffloVest product line. However, the company experienced a significant increase in operating and net losses due to higher operating expenses, including non-cash intangible asset amortization and earn-out expenses related to the AffloVest acquisition.
Total revenue increased 12% year-over-year to $48.0 million.
Revenue included $7.3 million from sales of airway clearance products.
Operating loss was $14.9 million, compared to $4.1 million in the prior year.
The company reaffirms full year 2022 total revenue guidance in the range of $235.0 million to $240.0 million.
The Company continues to expect full year 2022 total revenue in the range of $235.0 million to $240.0 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance